| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/01.RES.0000246086.93555.F3 |
| P698 | PubMed publication ID | 17038650 |
| P2093 | author name string | David J Granville | |
| Bruce M McManus | |||
| Maziar Rahmani | |||
| Rani P Cruz | |||
| P2860 | cites work | Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 |
| Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice | Q36130584 | ||
| P433 | issue | 8 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 801-815 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Allograft vasculopathy versus atherosclerosis | |
| P478 | volume | 99 |
| Q43103019 | A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy |
| Q28709166 | A luminance-based heart chip assay for assessing the efficacy of graft preservation solutions in heart transplantation in rats |
| Q41256425 | A reproducible mouse model of chronic allograft nephropathy with vasculopathy. |
| Q34083319 | A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation |
| Q42974102 | All-trans retinoic acid attenuates cardiac allograft vasculopathy in rats |
| Q37453921 | Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. |
| Q36571318 | Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis |
| Q35456617 | Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy |
| Q37994305 | Biomarkers of heart transplant rejection: the good, the bad, and the ugly! |
| Q42968537 | Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation |
| Q35244151 | Cardiac allograft vasculopathy: a donor or recipient induced pathology? |
| Q33860323 | Cardiac allograft vasculopathy: current knowledge and future direction |
| Q38206770 | Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. |
| Q40312464 | Co-localization of Disturbed Flow Patterns and Occlusive Cardiac Allograft Vasculopathy Lesion Formation in Heart Transplant Patients. |
| Q45919870 | Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model. |
| Q37136440 | Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography |
| Q38210159 | Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification |
| Q37391940 | Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy |
| Q33891755 | Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications. |
| Q44723997 | Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients. |
| Q104269335 | Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model |
| Q42952291 | Depletion of T regulatory cells promotes natural killer cell-mediated cardiac allograft vasculopathy |
| Q38300629 | Diagnosis and management of coronary allograft vasculopathy in children and adolescents. |
| Q33719657 | Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis |
| Q86047143 | Dose/time-dependent modulation of the endothelial function through induction agents: non-depleting versus depleting agents |
| Q63483985 | Dual-source cardiac computed tomography angiography (CCTA) in the follow-up of cardiac transplant: comparison of image quality and radiation dose using three different imaging protocols |
| Q36302824 | Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation |
| Q88342956 | Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts |
| Q40537003 | Endothelial Cell Apoptosis Induces TGF-β Signaling-Dependent Host Endothelial-Mesenchymal Transition to Promote Transplant Arteriosclerosis |
| Q38058477 | Endothelial dysfunction and cardiac allograft vasculopathy |
| Q35050517 | Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor |
| Q37208630 | Erythroblast transformation-specific 2 correlates with vascular smooth muscle cell apoptosis in rat heterotopic heart transplantation model |
| Q50117728 | Exosomes Expressing the Self-Antigens Myosin and Vimentin Play an Important Role in Syngeneic Cardiac Transplant Rejection Induced by Antibodies to Cardiac Myosin |
| Q79635428 | Extending donor source with bench coronary angiography: a case report |
| Q35139244 | Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy |
| Q90085905 | Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant |
| Q40410947 | HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs |
| Q34182265 | Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model |
| Q87912819 | How much do we really know about statins and transplant vasculopathy? |
| Q36512300 | Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease |
| Q59340216 | Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis |
| Q45992253 | IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy. |
| Q58122073 | IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation Blockade |
| Q28084366 | Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis |
| Q48942460 | Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy. |
| Q36976632 | Induction of vascular atrophy as a novel approach to treating restenosis. A review |
| Q36177467 | Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients |
| Q38218005 | Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy |
| Q36259538 | Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients |
| Q30429445 | Interleukin 17 in vascular inflammation |
| Q33969385 | Intimal fibrosis in human cardiac allograft vasculopathy |
| Q48367029 | Intimal thickening at coronary bifurcations in pediatric heart transplant recipients |
| Q35004399 | Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma |
| Q46034641 | Intraplaque hemorrhage in cardiac allograft vasculopathy. |
| Q35026402 | Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation |
| Q50910367 | Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection. |
| Q43511144 | Ly-6C(hi) monocytes: a potential target for preventing transplant arteriosclerosis? |
| Q99707149 | Mapping Transplant Arteriosclerosis Cell-by-Cell: A Path to New Immune Insights |
| Q37941478 | Mechanism of arterial remodeling in chronic allograft vasculopathy |
| Q37197706 | Mechanisms of chronic cardiac allograft rejection |
| Q42142657 | Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody |
| Q44813722 | Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition |
| Q38977171 | Neuropsychological functioning in preschool-aged children undergoing evaluation for organ transplant |
| Q42071637 | Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy |
| Q58721522 | PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism |
| Q47581797 | Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Heart Transplant Recipients With Transplant Coronary Arterial Vasculopathy |
| Q99629668 | Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management |
| Q39518477 | Perioperative Risk Factors of Cardiac Allograft Vasculopathy in the Long-Term Follow-up |
| Q35406626 | Peroxisome proliferator-activated receptor γ deficiency in T cells accelerates chronic rejection by influencing the differentiation of CD4+ T cells and alternatively activated macrophages |
| Q50096397 | Physical Exercise Is a Potential "Medicine" for Atherosclerosis |
| Q58701613 | Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography |
| Q53430932 | Proteinase-activated receptor-1 mediates allogeneic CD8(+) T cell-induced apoptosis of vascular endothelial cells. |
| Q37755793 | Psychiatric issues in pediatric organ transplantation |
| Q37207933 | Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy |
| Q38001437 | Restenosis and therapy |
| Q35864123 | Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation |
| Q33727090 | Role of Transient Receptor Potential Channels in Heart Transplantation: A Potential Novel Therapeutic Target for Cardiac Allograft Vasculopathy. |
| Q64894416 | Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. |
| Q35237562 | Smooth muscle progenitor cells: friend or foe in vascular disease? |
| Q33873655 | Spatial differences in the presence of FOXP3+ and GranzymeB+ T cells between the intra- and extravascular compartments in renal allograft vasculopathy |
| Q38808558 | Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter? |
| Q40074156 | Structure-function analysis of mouse Pur beta II. Conformation altering mutations disrupt single-stranded DNA and protein interactions crucial to smooth muscle alpha-actin gene repression |
| Q47212391 | Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis |
| Q38757789 | Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis |
| Q35060404 | The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy |
| Q38793606 | The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions |
| Q49916429 | The beginning at the end: non-invasive assessment of post-transplant coronary allograft vasculopathy at the microcirculatory level |
| Q33770904 | The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis |
| Q84486716 | The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat |
| Q37282249 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models |
| Q89118875 | The role of exosomes in allograft immunity |
| Q94526427 | The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy |
| Q38293492 | Therapeutic potential of HDL in cardioprotection and tissue repair |
| Q90306274 | Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients |
| Q85352011 | Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report |
| Q38681523 | Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis |
| Q39144570 | Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review. |
| Q34257142 | Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients |
| Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
| Q53154105 | Vascular smooth muscle cell apoptosis promotes transplant arteriosclerosis through inducing the production of SDF-1α. |
| Q45393346 | Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients |
| Q64051886 | ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes |
Search more.